^

Headlines

Philippines approves Pfizer’s coronavirus vaccine for emergency use

Xave Gregorio - Philstar.com

MANILA, Philippines (Updated 1:47 p.m.) — The Philippines approved Thursday the coronavirus vaccine of Pfizer Inc. and its German partner BioNTech SE for emergency use, making it the first COVID-19 jab to get the authorization needed for it to be rolled out by the government in its vaccination program.

The country's Food and Drug Administration granted an emergency use authorization (EUA) for the shot after finding that the benefit of using the vaccine, which has a 95% efficacy rate, to prevent COVID-19 infections outweighs known and potential risks.

The authorization clears the vaccine for use in people aged 16 and above. It can only be administered by health professionals who are trained to recognize and manage severe allergic reactions.

The EUA provides that Pfizer's Philippine unit would supply the vaccine to "emergency response stakeholders," including the Department of Health (DOH), the National Task Force Against COVID-19 (NTF) and whoever the two agencies authorize to procure coronavirus shots.

Among those who the DOH and the NTF can designate are public and private hospitals, health facilities of other national government agencies, local government units, and other members of the private sector.

The EUA also states that the Philippine unit of Pfizer would provide the required ultra-cold storage for the vaccines, unless it has an agreement with the DOH or the NTF providing otherwise.

But its emergency approval does not necessarily mean that the vaccine would be available for use, as the country has yet to strike a supply deal with Pfizer for doses of its jab.

Vaccine czar Carlito Galvez Jr., however, said that the country may secure doses of the Pfizer-BioNTech vaccine as early as February through the COVAX facility, a platform set up to ensure COVID-19 shots reach those in greatest need.

Pfizer, whose vaccine with BioNTech has been granted by the World Health Organization an emergency validation, submitted an application for emergency use authorization in the Philippines on December 23.

Several countries, including the US, the United Kingdom and Singapore, have already issued emergency use authorizations for the shot and have begun vaccinating their citizens for the coronavirus.

COVID-19 VACCINES

NOVEL CORONAVIRUS

PFIZER

As It Happens
LATEST UPDATE: January 1, 1970 - 8:00am
May 24, 2021 - 10:59am

The City Health Office of Lipa City reported on Sunday that 6,596 people have already received their jabs of Sinovac and AstraZeneca COVID-19 vaccines since the inoculation started two months ago.

The number represents 10% of the total 65,377 persons who registered to be scheduled for COVID vaccination.

Lipa City has a total population of 389,836 but not everyone registered for the vaccination. The city government also said 149,881 residents are aged 18 and below and currently “not qualified” for vaccination. —  The Filipino Connection/Marlon Luistro

January 6, 2021 - 3:37pm

British-Swedish pharmaceutical AstraZeneca has applied for emergency use authorization of its COVID-19 vaccine in the Philippines.

Philippine Food and Drug Administration Director General Eric Domingo confirms this in an interview with CNN Philippines.

AstraZeneca, along with its partner Oxford University in England, has so far made 50 million doses of its vaccine. In November, the British laboratory announced that its vaccine was on average 70% effective.

January 5, 2021 - 8:32am

The Armed Forces of the Philippines terminates its investigation into the unregulated Sinopharm vaccination of President Rodrigo Duterte's security detail following the chief executive's order not to cooperate with the probe.

Philstar
  • Latest
  • Trending
Latest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

FORGOT PASSWORD?
SIGN IN
or sign in with